{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:46:12Z","timestamp":1760888772346},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.rce.2013.01.014","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T20:16:47Z","timestamp":1364501807000},"page":"293-297","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes y osteoporosis: acci\u00f3n de las hormonas gastrointestinales sobre el hueso"],"prefix":"10.1016","volume":"213","author":[{"given":"A.","family":"Garc\u00eda-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Reyes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mu\u00f1oz-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2013.01.014_bib0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rce.2013.01.014_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rce.2013.01.014_bib0015","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestegaard","year":"2005","journal-title":"Diabetolologia"},{"key":"10.1016\/j.rce.2013.01.014_bib0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.rce.2013.01.014_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1534734611400256","article-title":"Review: The diabetic bone: a cellular and a molecular perspective","volume":"10","author":"Blakytny","year":"2011","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.rce.2013.01.014_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.rce.2013.01.014_bib0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1196\/annals.1333.082","article-title":"Advanced glycation end products and bone loss during aging","volume":"1043","author":"Odetti","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.rce.2013.01.014_bib0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2337\/diabetes.33.9.825","article-title":"Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization","volume":"33","author":"Goodman","year":"1984","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2013.01.014_bib0045","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.bone.2009.02.004","article-title":"Role of oxidative stress in diabetic bone disorder","volume":"45","author":"Hamada","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.rce.2013.01.014_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2007.10.008","article-title":"Osteoporosis among patients with type 1 and type 2 diabetes","volume":"34","author":"R\u00e4kel","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.rce.2013.01.014_bib0055","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bone.2009.06.006","article-title":"Vertebral fractures in males with type 2 diabetes treated with rosiglitazone","volume":"45","author":"Mancini","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.rce.2013.01.014_bib0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.01.014_bib0065","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.rce.2013.01.014_bib0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-010-0160-9","article-title":"Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus","volume":"28","author":"Kanazawa","year":"2010","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2013.01.014_bib0075","first-page":"S4","article-title":"Executive summary: Standards of medical care in diabetes-2012","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.01.014_bib0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-154-5-201103010-00307","article-title":"Screening for osteoporosis: U.S. preventive services task force recommendation statement","volume":"154","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rce.2013.01.014_bib0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jocd.2006.05.002","article-title":"Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference","volume":"9","author":"Binkley","year":"2006","journal-title":"J Clin Densitom"},{"issue":"Supl 1","key":"10.1016\/j.rce.2013.01.014_bib0090","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0014-2565(09)73246-1","article-title":"Escalas de riesgo de osteoporosis. La herramienta FRAX","volume":"209","author":"J\u00f3dar Jimeno","year":"2009","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.01.014_bib0095","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.rce.2013.01.014_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.rce.2013.01.014_bib0105","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.01.014_bib0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jc.2010-2435","article-title":"Impaired regulation of the incretin effect in patients with type 2 diabetes","volume":"96","author":"Bagger","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rce.2013.01.014_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-381517-0.00002-3","article-title":"Pleiotropic actions of the incretin hormones","volume":"84","author":"McIntosh","year":"2010","journal-title":"Vitam Horm"},{"key":"10.1016\/j.rce.2013.01.014_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","article-title":"Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years","volume":"24","author":"Klonoff","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rce.2013.01.014_bib0125","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.01.014_bib0130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/BF02877778","article-title":"Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis","volume":"24","author":"Dagdelen","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.rce.2013.01.014_bib0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.endonu.2012.01.002","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica para la evaluaci\u00f3n y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales","volume":"59","author":"Reyes Garc\u00eda","year":"2012","journal-title":"Endocrinol y Nutr"},{"issue":"Supl 1","key":"10.1016\/j.rce.2013.01.014_bib0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0014-2565(08)71780-6","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica en la osteoporosis postmenop\u00e1usica, glucocorticoidea y del var\u00f3n. Sociedad Espa\u00f1ola de Investigaci\u00f3n \u00d3sea y Metabolismo Mineral","volume":"208","author":"Gonz\u00e1lez Mac\u00edas","year":"2008","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.01.014_bib0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-5793(96)00895-2","article-title":"Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagonlike peptide 1","volume":"393","author":"Lamari","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.rce.2013.01.014_bib0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.rce.2013.01.014_bib0155","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.22243","article-title":"Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor","volume":"225","author":"Nuche-Berenguer","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.rce.2013.01.014_bib0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.rce.2013.01.014_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.rce.2013.01.014_bib0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JOE-11-0015","article-title":"GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia","volume":"209","author":"Nuche-Berenguer","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.rce.2013.01.014_bib0175","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.01.014_bib0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1463-1326.2010.01355.x","article-title":"Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes","volume":"13","author":"Bunck","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rce.2013.01.014_bib0185","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates \u03b2-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rce.2013.01.014_bib0190","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","article-title":"Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice","volume":"50","author":"Ferron","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.rce.2013.01.014_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.rce.2010.11.006","article-title":"Recomendaciones para el tratamiento farmacol\u00f3gico de la hiperglucemia en la diabetes tipo 2","volume":"211","author":"Men\u00e9ndez Torre","year":"2011","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.01.014_bib0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.rce.2011.05.014","article-title":"Manejo de la hiperglucemia en el paciente hospitalizado no cr\u00edtico con alimentaci\u00f3n oral","volume":"212","author":"Jansen","year":"2012","journal-title":"Rev Clin Esp"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425651300074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425651300074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T10:12:56Z","timestamp":1562839976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001425651300074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S001425651300074X"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2013.01.014","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}